lapatinib has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabowski, T; Grześkowiak, E; Karbownik, A; Klupczynska, A; Kokot, ZJ; Moch, M; Plewa, S; Sobańska, K; Szałek, E; Wolc, A | 1 |
1 other study(ies) available for lapatinib and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A pharmacokinetic study on lapatinib in type 2 diabetic rats.
Topics: Animals; Antineoplastic Agents; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Lapatinib; Male; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Wistar; Tandem Mass Spectrometry | 2018 |